Drug Product Manufacturing
Yaohai Bio-Pharma operates a 2,000㎡ aseptic drug product facility,with production lines designed to meet EU and US GMP requirements
August 6, 2025
No Comments
Menu
Yaohai Bio-Pharma operates a 2,000㎡ aseptic drug product facility,with production lines designed to meet EU and US GMP requirements
Yaohai Bio-Pharma operates five drug substance production lines,offering GMP-compliant bioreactor scales from 50L to 2000L in full compliance with NMPA, FDA, and EMA standards
Offering quality analysis for biologics such as recombinant proteins and plasmids, including method development and validation, stability studies, and reference standard establishment
Comprehensive formulation development for diverse biologics, with fill-finish options including lyophilized and liquid vials, pre-filled syringes, and cartridges
Integrated process development with microbial expression systems, covering cell banking, fermentation, purification, formulation, quality analysis, technology transfer, and validation
Providing codon optimization, plasmid construction, expression strain development, and high-yield strain screening services
based on supplied amino acid or DNA sequence
